Patent AnalyticsExaminers
Menu

Application

16005137 · DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST

Filed 2018-06-11 · Abandoned The official file ↗ · Art unit 1621 · Examiner Kathrien Ann Hartsfield Hard · CPC A61K 31/137 · Novartis AG · NOVARTIS PHARMACEUTICAL CORPORATION

Office actions
1
first was Non-final rejection
RCEs
0
no appeal
To first action
0.8 mo
to disposition 8.3 mo
Statutes raised
103
1 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in